238 x 160
Oncology Information Systems Market Investment Analysis & Forecast, 2026-2035
Market Insight: Integrated Oncology Information Systems Are Reshaping Cancer Care Delivery
The global oncology information systems market was valued at USD 3.4 billion in 2026 and is estimated to reach USD 3.63 billion in 2027. The market is projected to expand to USD 7.27 billion by 2036, registering a compound annual growth rate (CAGR) of 7.89% during 2027–2036. This growth reflects the increasing importance of digital infrastructure in cancer diagnosis, treatment planning, clinical documentation, and patient management. As oncology care becomes more complex, healthcare providers are prioritizing integrated software platforms that connect clinical information, treatment workflows, and operational data.
Regional Analysis: North America Leads While Asia Pacific Offers Growth Opportunities
Regional performance in the oncology information systems market reflects differences in healthcare infrastructure, digital maturity, cancer treatment capacity, and investment priorities. North America holds the leading market position, while Asia Pacific is emerging as an important growth market as healthcare providers modernize oncology services.
North America: Established Infrastructure Supports Market Leadership
North America accounted for 42.05% of the market in 2026. Its leading position is supported by advanced cancer care infrastructure, integrated hospital IT systems, and established demand for coordinated oncology workflows.
Healthcare institutions in the region generally operate within sophisticated clinical environments where digital documentation, treatment planning, and information exchange are important operational requirements. These conditions support demand for oncology software that can integrate with existing hospital systems and specialized treatment technologies.
Asia Pacific: Healthcare Modernization Creates Expansion Potential
Asia Pacific is projected to expand at a CAGR of 8.93%. Growth is associated with healthcare modernization, the adoption of digital workflows, and efforts to improve treatment coordination across expanding hospital networks.
The region presents opportunities for oncology information system providers because healthcare institutions need scalable solutions that can support growing patient volumes and increasingly sophisticated cancer treatment services. Digital platforms can help hospitals coordinate clinical documentation, treatment planning, and information exchange across departments and facilities.
Industry Challenge: Interoperability and Clinical Workflow Integration Remain Critical Barriers
Despite the growing adoption of oncology information systems, integrating digital platforms into complex healthcare environments remains a significant challenge. The effectiveness of these systems depends not only on their technical capabilities but also on their ability to exchange information reliably and fit into established clinical workflows.
Fragmented Healthcare Technology Environments
Hospitals often operate separate systems for electronic health records, diagnostic imaging, laboratory information, radiation therapy, scheduling, and billing. When these applications cannot exchange information efficiently, healthcare professionals may need to enter data repeatedly or navigate multiple interfaces.
Such fragmentation can undermine the operational benefits of oncology software. A treatment planning platform may offer sophisticated functionality, for example, but its practical value can be limited if clinicians cannot access the necessary patient information efficiently.
Implementation Costs and Workforce Adaptation
Introducing an oncology information system can require software configuration, data migration, staff training, cybersecurity controls, and integration with existing equipment. These activities create financial and operational demands, particularly for institutions with limited IT resources.
Clinical adoption is another consideration. Healthcare professionals need systems that support established treatment procedures rather than introduce unnecessary administrative work. Poorly designed interfaces or complicated workflows can discourage consistent use, even when the underlying technology is capable.
Technology Comparison: Specialized Treatment Planning Versus Cloud-Based Oncology Analytics
Oncology information systems encompass multiple technology categories, each addressing different clinical and operational requirements. Two important approaches are specialized treatment planning platforms and cloud-based oncology analytics solutions.
Although both support cancer care delivery, they serve different primary purposes and offer distinct opportunities for healthcare providers and technology companies.
|
Comparison Factor |
Specialized Treatment Planning Systems |
Cloud-Based Oncology Analytics |
|
Primary purpose |
Support treatment preparation, planning, and execution |
Support performance monitoring, reporting, and operational analysis |
|
Core information |
Treatment parameters, clinical information, and planning data |
Operational indicators, utilization information, and clinical performance data |
|
Main users |
Radiation oncologists, medical physicists, and treatment teams |
Healthcare administrators, clinical leaders, and operational managers |
|
Principal value |
Supports treatment precision and structured clinical workflows |
Improves visibility into performance and resource utilization |
|
Integration priorities |
Treatment equipment, imaging systems, and clinical applications |
Hospital information systems, data sources, and reporting platforms |
|
Key implementation considerations |
Clinical validation, technical compatibility, and workflow consistency |
Data quality, secure access, and consistent reporting definitions |
|
Strategic opportunity |
Advanced planning capabilities and integrated treatment workflows |
Scalable analytics, customizable dashboards, and data-driven management |
Treatment Planning Systems: Clinical Precision and Workflow Control
Specialized treatment planning platforms are designed to support the preparation and delivery of cancer treatments. In radiation oncology, these systems help professionals organize relevant clinical information and develop treatment plans suited to individual patients.
Recent developments demonstrate continued investment in this area. Cosylab received FDA 510(k) clearance for PlanOne™, a treatment planning system for particle therapy, in June 2026. The platform uses a GPU-accelerated Monte Carlo engine for radiobiologically informed dose planning within a unified clinical workflow.
Cloud-Based Analytics: Operational Visibility and Decision Support
Cloud-based analytics platforms address a different need: helping healthcare institutions understand performance across their oncology operations.
RaySearch Laboratories' RayIntelligence v2025, released in September 2025, introduced customizable dashboards for monitoring indicators such as plan quality trends, machine utilization, protocol adherence, and clinical outcomes.
These capabilities can help institutions identify operational bottlenecks and evaluate resource use. However, their effectiveness depends on reliable data collection, appropriate performance indicators, and integration with relevant information systems.
Geographic Opportunity: Four Markets to Watch in Oncology Information Systems
Regional expansion requires more than identifying markets with growing healthcare demand. Oncology information system providers must evaluate digital infrastructure, clinical capabilities, procurement priorities, and the compatibility of their products with local healthcare environments.
The following four countries represent relevant strategic markets within the broader regional outlook.
United States: Advanced Clinical Technology and Integration
The United States is an important market for sophisticated oncology software because of its advanced cancer treatment infrastructure and established use of hospital IT systems.
Opportunities include specialized treatment planning, AI-supported clinical workflows, analytics, and integration across multidisciplinary cancer care teams.
For vendors, product differentiation and compatibility with existing healthcare technology are important considerations. Solutions must demonstrate clinical relevance and operational value while addressing institutional requirements for security, reliability, and regulatory compliance.
Canada: Coordinated Care and Digital Infrastructure
Canada presents opportunities for oncology platforms that support information exchange, standardized documentation, and coordination across healthcare institutions.
Solutions that help connect clinical teams and improve visibility into treatment workflows may be relevant to organizations seeking more consistent digital processes.
China: Healthcare Modernization and Scalable Solutions
China is strategically relevant because healthcare modernization and expanding hospital capabilities can create demand for digital tools supporting complex clinical services.
Oncology software providers may find opportunities in treatment planning, clinical data management, and operational analytics, particularly where institutions are developing more integrated digital workflows.
India: Digital Adoption and Hospital Network Expansion
India offers opportunities for oncology information systems as healthcare providers seek to strengthen digital capabilities and coordinate services across hospitals and specialized cancer centers.
Platforms that integrate clinical documentation, treatment planning, and operational reporting may help institutions manage increasingly complex workflows.
Cost considerations remain important, making implementation flexibility and scalable functionality relevant purchasing factors. Vendors should also account for differences in digital infrastructure and technical resources across healthcare organizations.
Competitive Landscape: Vendors Are Expanding Beyond Standalone Oncology Software
Competition in the oncology information systems market increasingly reflects the ability to combine specialized clinical functionality with connectivity, analytics, and operational efficiency.
Recent developments from Cosylab, Flatiron Health, GE HealthCare, and RaySearch Laboratories illustrate different approaches to this opportunity.
Cosylab: Advancing Specialized Treatment Planning
Cosylab received FDA 510(k) clearance for its PlanOne™ particle therapy treatment planning system in June 2026.
The system combines GPU-accelerated Monte Carlo computation with radiobiologically informed dose planning in a unified clinical workflow.
The development highlights the importance of specialized treatment capabilities and advanced computation. It also demonstrates how regulatory milestones can support the introduction of technologies designed for complex clinical applications.
Flatiron Health: Strengthening Clinical Data Infrastructure
In February 2026, Flatiron Health launched AI-powered prostate cancer datasets covering approximately 400,000 patients across the US, UK, and Germany.
The datasets aggregate structured and unstructured electronic health record data to support multimodal clinical intelligence, therapy development, and clinical evidence generation.
This development reflects the growing importance of organized real-world clinical data in oncology research. It also illustrates how data infrastructure can support applications extending beyond routine documentation into research and treatment development.
GE HealthCare: Improving Connected Radiation Therapy Workflows
In September 2025, GE HealthCare updated its Intelligent Radiation Therapy software to improve workflow management and connectivity.
The update focused on integrating third-party applications and AI-supported tools to streamline the diagnostic-to-treatment pathway.
This approach emphasizes connectivity as a competitive differentiator. Healthcare institutions increasingly need software that works across existing clinical systems, making integration capabilities important alongside individual product features.
RaySearch Laboratories: Building a Broader Digital Oncology Environment
RaySearch Laboratories introduced several product updates during 2025.
In September 2025, the company released RayIntelligence v2025, adding customizable dashboards for monitoring operational and clinical indicators.
In June 2025, RayCare v2025 introduced enhanced integrations for patient documentation and imaging workflows, including Microsoft Word integration, automated DICOM Modality Worklist capabilities, and HL7 inbound scheduling.
In May 2025, RaySearch released RayStation v2025, with enhancements to core clinical workflows intended to improve radiation therapy planning and execution.
Recent Industry News: Product Developments Highlight the Shift Toward Connected Oncology Workflows
Recent announcements across oncology software demonstrate growing emphasis on specialized treatment capabilities, clinical data infrastructure, interoperability, and analytics. The following developments illustrate how companies are addressing different aspects of digital cancer care.
June 2026: Cosylab Receives FDA Clearance for PlanOne™
Cosylab received FDA 510(k) clearance for PlanOne™, its particle therapy treatment planning system. The platform incorporates GPU-accelerated Monte Carlo computation and radiobiologically informed dose planning within a unified clinical workflow.
The development highlights continued technological advancement in specialized radiation oncology applications. Regulatory clearance is an important milestone, although broader adoption will also depend on clinical implementation, compatibility, and institutional requirements.
February 2026: Flatiron Health Launches Prostate Cancer Datasets
Flatiron Health launched AI-powered prostate cancer datasets aggregating structured and unstructured electronic health record information across the US, UK, and Germany.
The datasets are intended to support clinical intelligence, therapy development, and evidence generation.
The announcement illustrates the increasing importance of real-world clinical data in oncology research. By organizing information from different sources, such platforms can support more comprehensive research workflows, provided that data quality, privacy, and analytical validity are appropriately managed.
September 2025: GE HealthCare Updates Intelligent Radiation Therapy Software
GE HealthCare updated its Intelligent Radiation Therapy software to improve connectivity and workflow management, including integration with third-party applications and AI-supported tools.
The development reflects the importance of connecting diagnostic and treatment processes. For healthcare institutions, better integration can help reduce fragmentation between clinical applications, although actual benefits depend on local system compatibility and implementation.
June 2025: RaySearch Introduces RayCare v2025
RaySearch Laboratories released RayCare v2025 with enhanced patient documentation and imaging integrations. The update included Microsoft Word integration, automated DICOM Modality Worklist capabilities, and HL7 inbound scheduling.
These enhancements highlight the commercial importance of reducing friction between oncology applications and hospital information systems. Integration-focused improvements can make digital platforms more practical for institutions managing complex clinical workflows.
May 2025: RaySearch Releases RayStation v2025
RaySearch Laboratories released RayStation v2025 with improvements to core clinical workflows supporting radiation therapy planning and execution.
The update reinforces the continuing role of specialized treatment planning software in the oncology technology landscape. Enhancements to established platforms can help vendors maintain relevance while addressing evolving clinical and operational requirements.
Read more about this report @ https://www.fundamentalbusinessinsights.com/industry-report/oncology-information-systems-market-14551
About
Fundamental Business Insights:
Fundamental Business Insights is global market research and consulting company which is engaged in providing in depth market reports to its various types of clients like industrial sectors, financial sectors, universities, non-profit, and corporations. Our goal is to offer the correct information to the right stakeholder at the right time, in a format that enables logical and informed decision making. We have a team of consultants who have experience in offering executive level blueprints of markets and solutions. Our services include syndicated market studies, customized research reports, and consultation.
Contact us:
Robbin Fernandez
Head of Business Development
Fundamental Business Insights and Consulting
Email: sales@fundamentalbusinessinsights.com
Read This Report in Regional Languages -
